VentureMed Group
2865 N. Reynolds Road
Suite 220A
Toledo
Ohio
43615
United States
Tel: 567-661-0768
Fax: 419-558-4171
Website: http://www.venturemedgroup.com/
Email: info@venturemedgroup.com
About VentureMed Group
VentureMed Group, Inc. is a commercial-stage medical device company that develops and markets cost-effective interventional devices to improve the treatment of peripheral artery disease. The Company's innovative product platforms are designed to improve clinical outcomes and reduce procedural costs.YEAR FOUNDED:
2012
LEADERSHIP:
CEO: Gary L. Smith
CSO: John P. Pigott
COO and CFO: Brent Cousino
7 articles about VentureMed Group
-
VentureMed Receives Transitional Pass-through Payment (TPT) for FLEX Vessel Prep™ System
11/8/2023
VentureMed Group, Inc. announced that the Center for Medicare & Medicaid Services has granted The FLEX Vessel Prep™ System a transitional pass-through payment category and a new HCPCS C-code effective January 1, 2024 and will remain in effect for the following two to three years.
-
VentureMed Group Raises Bridge Financing and Embarks on 2023 Objectives
1/31/2023
VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease announced that the company has raised bridge financing to support its 2023 objectives.
-
FLEX Vessel Prep™ System Data Presented at New Cardiovascular Horizons Conference Shows Key Findings including Luminal Gain
6/4/2019
VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons Annual Conference, May 29-31, in New Orleans, Louisiana.
-
VentureMed Group Grows with Move to Minneapolis MedTech Community
5/16/2019
Company will be relocating from its current facilities in the ProMedica Innovations Center in Toledo, Ohio to Minneapolis, Minnesota as the Company continues to develop and grow.
-
Swiss Enrollment Begins for FLEX Vessel Preparation System: The BELONG Study
1/17/2019
Actively enrolling up to 150 patients to evaluate lumen patency at one year obtained by arterial vessel preparation with the FLEX Vessel Preparation System prior to conventional endovascular recanalization of the superficial femoral artery (SFA) and popliteal artery (PA).
-
VentureMed Group Begins Enrollment in FLEX Scoring Catheter Arteriovenous Access Site Study
6/18/2018
VentureMed Group, Inc. announced initial enrollment in a new non-randomized, single-site, prospective study to evaluate the safety and efficacy of the FLEX Scoring Catheter with a Drug Coated Balloon (DCB) balloon in the maintenance of arteriovenous access sites.
-
VentureMed Group Raises $15 Million Series B Equity Financing
8/15/2017